Jay Y. Rhew - Publications

Integrated left ventricular geometry-function phenotypes and long-term outcomes after acute myocardial infarction.

Journal: Frontiers in cardiovascular medicine

Published: April 23, 2026

LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study.

Journal: Journal of clinical medicine

Published: December 27, 2025

Complete revascularization timing in ST-segment elevation myocardial infarction and multivessel disease with heart failure: the OPTION-STEMI trial.

Journal: European heart journal

Published: August 03, 2025

Immediate versus staged complete revascularisation during index admission in patients with ST-segment elevation myocardial infarction and multivessel disease (OPTION-STEMI): a multicentre, non-inferiority, open-label, randomised trial.

Journal: Lancet (London, England)

Published: May 07, 2025

Dual antiplatelet therapy after percutaneous coronary intervention according to bleeding risk (HOST-BR): an open-label, multicentre, randomised clinical trial.

Journal: Lancet (London, England)

Published: February 16, 2025

Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: June 18, 2024

Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.

Journal: American heart journal

Published: February 16, 2024

Clinical Outcome after Everolimus-Eluting Stent Implantation for Small Vessel Coronary Artery Disease: XIENCE Asia Small Vessel Study.

Journal: Chonnam medical journal

Published: May 30, 2023

Intravascular Ultrasound Guided Intervention in Calcified Coronary Lesions Showed Good Clinical Outcomes during One Year Follow-Up.

Journal: Journal of clinical medicine

Published: May 11, 2023

Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: August 03, 2022

The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention.

Journal: Korean circulation journal

Published: December 03, 2021

Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Journal: The American journal of cardiology

Published: August 04, 2020